EYEGATE PHARMACEUTICALS INC - COM (EYEG)

CUSIP: 30233M107

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
321,819
Share change
-19,577
Total reported value
$821,000
Price per share
$2.56
Number of holders
10
Value change
+$129,668
Number of buys
7
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q1 2017

As of 31 Mar 2017, EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 321,819 shares. The largest 10 holders included VANGUARD GROUP INC, KCG HOLDINGS, INC., IFP Advisors, Inc, BlackRock Inc., TWO SIGMA SECURITIES, LLC, Vantage Investment Advisors, LLC, FNY Partners Fund LP, MORGAN STANLEY, DEUTSCHE BANK AG\, and Creative Planning. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.